![Frédéric Revah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frédéric Revah
Directeur Général chez
Genethon
Profil
Currently, Frédéric Revah is Chief Executive Officer at Genethon since 2010, Chairman at Atamyo Therapeutics SAS, and Member of the Management Board at Hera Diagnostics SAS. Formerly, the roles include Chief Executive Officer at Sepal Pharma SA in 2011, Chairman at Yposkesi, Director at Eurofins-Cerep SA, and Head of the Gene Therapy Department at Sanofi from 1992 to 1998.
Education includes an undergraduate degree from Ecole Polytechnique in 1985 and a doctorate from Université de Paris 5 René Descartes in 1991.
Postes actifs de Frédéric Revah
| Sociétés | Poste | Début |
|---|---|---|
Genethon
 Genethon BiotechnologyHealth Technology Develops gene therapy products for rare diseases | Directeur Général | 01/01/2010 |
Hera Diagnostics SAS | Corporate Officer/Principal | 14/03/2011 |
Atamyo Therapeutics SAS
 Atamyo Therapeutics SAS BiotechnologyHealth Technology Develops gene therapies for neuromuscular diseases | Président | - |
Anciens postes connus de Frédéric Revah
| Sociétés | Poste | Fin |
|---|---|---|
Yposkesi
 Yposkesi BiotechnologyHealth Technology Manufactures gene and cell therapy drugs | Président | 01/04/2021 |
| SANOFI | Corporate Officer/Principal | 01/01/1998 |
| EUROFINS CEREP | Directeur/Membre du Conseil | - |
Sepal Pharma SA
 Sepal Pharma SA Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Directeur Général | - |
Formation de Frédéric Revah
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Eurofins-Cerep SA
 Eurofins-Cerep SA Miscellaneous Commercial ServicesCommercial Services Offers preclinical drug discovery services | Commercial Services |
Ecole Polytechnique
 Ecole Polytechnique Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sepal Pharma SA
Sepal Pharma SA Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Health Technology |
Université de Paris 5 René Descartes
 Université de Paris 5 René Descartes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genethon
Genethon BiotechnologyHealth Technology Develops gene therapy products for rare diseases | Health Technology |
Hera Diagnostics SAS | |
Yposkesi
Yposkesi BiotechnologyHealth Technology Manufactures gene and cell therapy drugs | Health Technology |
Atamyo Therapeutics SAS
Atamyo Therapeutics SAS BiotechnologyHealth Technology Develops gene therapies for neuromuscular diseases | Health Technology |
